Gqg Partners LLC Astrazeneca PLC Transaction History

Gqg Partners LLC

$63.6 Billion
Q3 2024

A detailed history of Gqg Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gqg Partners LLC holds 5,475,142 shares of AZN stock, worth $373 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

5,475,142

Previous 2,999,584 82.53%

Holding current value

$373 Million

Previous $234 Million 82.37%

% of portfolio

0.67%

Previous 0.36%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $190 Million - $217 Million	2,475,558 Added 82.53%	5,475,142 $427 Million
Q2 2024 Aug 12, 2024	BUY	$66.81 - $80.83 $186 Million - $225 Million	2,780,090 Added 1266.59%	2,999,584 $234 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $832 Million - $949 Million	-13,638,889 Reduced 98.42%	219,494 $14.9 Million
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $11.6 Million - $13 Million	-187,489 Reduced 1.33%	13,858,383 $933 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $464 Million - $513 Million	-7,152,626 Reduced 33.74%	14,045,872 $951 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $24.3 Million - $26.3 Million	-346,889 Reduced 1.61%	21,198,498 $1.52 Billion
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $275 Million - $311 Million	4,348,916 Added 25.29%	21,545,387 $1.5 Billion
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $64 Million - $83.2 Million	-1,181,260 Reduced 6.43%	17,196,471 $1.17 Billion
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $17.9 Million - $45.9 Million	-337,929 Reduced 1.81%	18,377,731 $1.01 Billion
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $25.8 Million - $30.9 Million	434,979 Added 2.38%	18,715,660 $1.24 Billion
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $65.4 Million - $78.7 Million	-1,173,071 Reduced 6.03%	18,280,681 $1.21 Billion
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $52.6 Million - $62.1 Million	973,398 Added 5.27%	19,453,752 $1.13 Billion
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $103 Million - $112 Million	1,848,321 Added 11.11%	18,480,354 $1.11 Billion
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $59.1 Million - $73.5 Million	1,220,580 Added 7.92%	16,632,033 $996 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $1.94 Million - $2.23 Million	41,054 Added 0.27%	15,411,453 $766 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $224 Million - $268 Million	4,616,470 Added 42.93%	15,370,399 $768 Million
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $83.2 Million - $95.8 Million	1,567,375 Added 17.06%	10,753,929 $589 Million
Q2 2020 Aug 19, 2020	BUY	$43.1 - $55.31 $396 Million - $508 Million	9,186,554 New	9,186,554 $486 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $342 Million - $439 Million	-7,937,391 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $35.4 Million - $48.1 Million	937,164 Added 13.39%	7,937,391 $355 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $45.5 Million - $54 Million	1,071,004 Added 18.06%	7,000,227 $349 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $34 Million - $38.5 Million	846,530 Added 16.66%	5,929,223 $264 Million
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $2.71 Million - $3.02 Million	-72,576 Reduced 1.41%	5,082,693 $210 Million
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $76.6 Million - $92.8 Million	2,157,252 Added 71.96%	5,155,269 $208 Million
Q4 2018 Feb 15, 2019	SELL	$36.86 - $41.49 $768 Million - $865 Million	-20,848,027 Reduced 87.43%	2,998,017 $114 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $780 Million - $878 Million	21,157,256 Added 786.87%	23,846,044 $906 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $93.5 Million - $107 Million	2,688,788 New	2,688,788 $106 Million

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $211B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gqg Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gqg Partners LLC with notifications on news.

Account